Lumosa Therapeutics Co., Ltd.
8 clinical trials · Sponsor
◉ Watch Lumosa Therapeutics Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Safety and Efficacy of Multiple Doses of LT3001 Drug Product in AIS Subjects (NCT05403866) | Lumosa Therapeutics Co., Ltd. | 2022-08-17 |
| A Study to Evaluate the Safety and Efficacy of LT3001 Drug Product in Subjects AIS Undergoing EVT (NCT05198323) | Lumosa Therapeutics Co., Ltd. | 2022-08-11 |
| A Study to Evaluate Safety and PK of Multiple Doses of LT3001 Drug Product and Drug-drug Interaction in Healthy Subjects (NCT04809818) | Lumosa Therapeutics Co., Ltd. | 2021-03-21 |
| Study to Investigate the Safety of LT5001 Drug Product for Uremic Pruritus in Hemodialysis Patients (NCT04393675) | Lumosa Therapeutics Co., Ltd. | 2020-05-14 |
| A Bioavailability Study of NALDEBAIN ER Injection and Nalbuphine Injection in Healthy Volunteers. (NCT04256434) | Lumosa Therapeutics Co., Ltd. | 2020-01-31 |
| A Study to Evaluate the Safety and Potential Efficacy of LT3001 Drug Product in Subjects With AIS (NCT04091945) | Lumosa Therapeutics Co., Ltd. | 2020-01-27 |
Track Lumosa Therapeutics Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.